相关实验视频
Updated: Jul 14, 2025

06:26
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
347
在胸腔内血管大动脉修复后的大动脉重塑,用于非急性不复杂的B型大动脉剖析
Yoshikatsu Nomura1, Ryota Kawasaki2, Yutaka Koide2
1Department of Cardiovascular Surgery, Hyogo Prefectural Harima-Himeji General Medical Center, Himeji, Hyogo, Japan.
Annals of vascular surgery
|October 7, 2023
概括
胸内血管大动脉修复 (TEVAR) 无并发型B型大动脉剖析 (TBAD) 实现了55%的大动脉重塑. 更大的大动脉直径和从剖析开始到TEVAR的时间更长,阻碍了成功的重塑.
科学领域:
- 心血管外科心血管外科
- 血管外科 血管外科
- 血管内干预 血管内干预
背景情况:
- 胸内血管大动脉修复 (TEVAR) 越来越多地用于斯坦福B型大动脉剖析 (TBAD).
- 大动脉重塑是TEVAR在TBAD中已知的结果.
- 在非急性,不复杂的TBAD中影响改造的因素需要进一步调查.
研究的目的:
- 评估大动脉直径与外科手术从发作的时间之间的关系.
- 评估它们在TEVAR治疗无并发非急性结核病后对大动脉重塑的影响.
主要方法:
- 对40名接受TEVAR治疗的亚急性/慢性无并发性TBAD患者的回顾性分析.
- 纳入标准:专利假光,至少6个月的随访.
- 改造和非改造组之间的数据比较.
主要成果:
- 在97.5%的病例中TEVAR成功;55%实现了晚期的大动脉重塑.
- 术前最大大动脉直径 (PMAD) >45毫米预计没有重塑 (AUC=0.917).
- 从发病到干预的时间>6.3个月预测不重塑 (AUC=0.743).
结论:
- 对非急性无并发性结核病的TEVAR产生了55%的晚期大动脉重塑率.
- 一个PMAD>45毫米或干预>6.3个月后的发病阻碍了重塑.
- 这些发现有助于在TBAD中选择TEVAR的患者和时间.
相关概念视频
Aneurysm III: Interprofessional Care
9
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
9
Aortic Regurgitation III: Medical Management
24
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
24
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
23
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
23
Aortic Regurgitation I: Introduction
10
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
10
Aneurysm II: Clinical Manifestations and Diagnostic Studies
10
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
10

